Abstract
Due to its profound therapeutic consequences, the distinction between thymoma and T-lymphoblastic lymphoma in needle biopsies is one of the most challenging in mediastinal pathology. One essential diagnostic criterion favouring thymoma is the demonstration of increased numbers of keratin-positive epithelial cells by immunohistochemistry. Loss of keratin expression in neoplastic epithelial cells could lead to detrimental misdiagnoses. We here describe a series of 14 thymic epithelial tumours (11 type B2 and B3 thymomas, 3 thymic carcinomas) with loss of expression of one or more keratins. Cases were analysed for expression of various keratins and desmosomal proteins by immunohistochemistry and immunofluorescence and compared with 45 unselected type B thymomas and 24 thymic carcinomas arranged in a multitissue histological array. All 14 cases showed highly reduced expression of at least one keratin, three cases were completely negative for all keratins studied. Of the 14 cases, 13 showed strong nuclear expression of p63. Expression of desmosomal proteins was preserved, suggesting intact cell contact structures. Loss of expression of broad-spectrum-keratins and K19 was observed in 3 and 5 % of unselected thymomas and in 30 and 60 % of thymic carcinomas. A proportion of keratin-depleted thymomas contained giant cells, reminiscent of thymic nurse cells. Loss of keratin expression in type B2 and B3 thymomas is an important diagnostic pitfall in the differential diagnosis with T-lymphoblastic lymphoma and can be expected in 5 % of cases. A panel of epithelial markers including p63 is warranted to ensure correct diagnosis of keratin-negative mediastinal tumours.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bersvendsen H, Kolstad A, Blystad AK, Aurlien E, Fossa A, Kvaloy SO, Holte H, Lauritzsen GF (2013) Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma Acta Oncol
Borowitz MJ, Chan JKC (2008) T lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO Classification of Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 176–179
Friedman HD, Hutchison RE, Kohman LJ, Powers CN (1996) Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation. Diagn Cytopathol 14:165–169, discussion 169–171
Hendrix TM, Chilukuri RV, Martinez M, Olushoga Z, Blake A, Brohi M, Walker C, Samms M, Guyden JC (2010) Thymic nurse cells exhibit epithelial progenitor phenotype and create unique extra-cytoplasmic membrane space for thymocyte selection. Cell Immunol 261:81–92
Kuo T (2000) Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 36:403–414
Li S, Juco J, Mann KP, Holden JT (2004) Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 121:268–274
Müller-Hermelink HK, Engel P, Kuo TT, Strobel P, Marx A, Harris NL, Möller P, Menestrina F, Shimosato Y, Asamura H, Masaoka A, Sobin LH (2004) Tumours of the thymus: introduction. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) World Health Organization Classification of tumours. pathology and genetics of tumours of the lung, thymus and heart. IARC Press, Lyon, pp 145–151
Muller-Hermelink HK, Marx A (2000) Thymoma Curr Opin Oncol 12:426–433
Müller-Hermelink HK, Sng I, Palestro G, Molina TJ, Laeng RH, Harris NL, Zhang PJ, Marx A (2004) Type B2 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 161–163
Palestro G, Chiarle R, Marx A, Müller-Hermelink HK, Sng I (2004) Type B1 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 159–160
Patel DD, Whichard LP, Radcliff G, Denning SM, Haynes BF (1995) Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 15:80–92
Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174:169–174
Senoo M, Pinto F, Crum CP, McKeon F (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523–536
Shezen E, Okon E, Ben-Hur H, Abramsky O (1995) Cytokeratin expression in human thymus: immunohistochemical mapping. Cell and Tissue Res 279:221–231
Strobel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Muller-Hermelink HK, Peterson P, Marx A (2008) Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci 1132:143–156
Strobel P, Hohenberger P, Marx A (2010) Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 5:S286–S290
Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF (2012) Thymoma and thymic carcinoma. Gen Thoracic and Cardiovasc Surg 60:1–12
Acknowledgments
AM and PS are supported by BMBF grant 01DL12027. IH and PS are supported by DFG grant STR 638/2-1
Conflict of interest
Authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adam, P., Hakroush, S., Hofmann, I. et al. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Virchows Arch 465, 313–320 (2014). https://doi.org/10.1007/s00428-014-1606-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-014-1606-6